Tehran University of Medical Sciences

Science Communicator Platform

Share By
Cd147 and Cyclophilin A: A Promising Potential Targeted Therapy for Covid-19 and Associated Cancer Progression and Chemo-Resistance Publisher



Bakhtiyari M1, 2 ; Haji Aghasi A3 ; Banihashemi S4 ; Abbassioun A5 ; Tavakol C6 ; Zalpoor H2, 7
Authors

Source: Infectious Agents and Cancer Published:2023


Abstract

Coronavirus disease-2019 (COVID-19), as a worldwide serious issue has been shown to lead to progression and poor outcomes in cancer patients. The underlying mechanisms for SARS-CoV-2 infection’s adverse effects on cancer patients have not been fully understood. We hypothesized that CD147 and Cyclophilin A (CyPA) not only can play a significant role in infection severity but also can contribute to cancer progression and chemotherapy resistance in cancer patients with COVID-19. In addition, we hypothesized that the expression of both CD147 and CyPA could be increased by Hypoxia-inducible Factor-1 alpha (HIF-1α) activation during hypoxic conditions that occurred during COVID-19. Therefore, this evidence can open a new window in the management of cancer patients during the pandemic and therapeutic approaches targeting CD147 and CyPA could be a potentially promising therapeutic approach for such patients. © 2023, The Author(s).
Related Docs
View other Related Docs
1. Challenges Posed by Covid-19 in Cancer Patients: A Narrative Review, Cancer Medicine (2022)
2. Considerations for Interactions of Drugs Used for the Treatment of Covid-19 With Anti-Cancer Treatments, Critical Reviews in Oncology/Hematology (2020)
3. The Contributory Role of Lymphocyte Subsets, Pathophysiology of Lymphopenia and Its Implication As Prognostic and Therapeutic Opportunity in Covid-19, International Immunopharmacology (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (4)
Mohammad Hossein Nicknam (1)
Other Related Docs
4. Dysregulation of the Immune Response in Coronavirus Disease 2019, Cell Biology International (2021)
5. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
6. Covid-19 and Cancer: A Comparative Case Series, Cancer Treatment and Research Communications (2021)
7. Covid-19 in Patients With Cancer: Risks and Precautions, American Journal of Emergency Medicine (2021)
8. Risk Factors for Adverse Outcomes of Covid-19 Patients: Possible Basis for Diverse Responses to the Novel Coronavirus Sars-Cov-2, Life Sciences (2021)
9. Cancer and Coronavirus Disease (Covid-19): Comorbidity, Mechanical Ventilation, and Death Risk, Journal of Gastrointestinal Cancer (2021)
10. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
11. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
12. Towards Treatment Planning of Covid-19: Rationale and Hypothesis for the Use of Multiple Immunosuppressive Agents: Anti-Antibodies, Immunoglobulins, and Corticosteroids, International Immunopharmacology (2020)
13. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
14. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
15. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
16. A Meta-Analysis for Prevalence of Lung Cancer Patients With Sars-Cov-2 Infection During the Covid-19 Pandemic, Eurasian Journal of Medicine and Oncology (2022)
17. Current Evidence on the Use of Anakinra in Covid-19, International Immunopharmacology (2022)
18. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
19. Covid-19 Immunotherapy: Treatment Based on the Immune Cell-Mediated Approaches, International Immunopharmacology (2022)
20. Molecular Signaling Pathways, Pathophysiological Features in Various Organs, and Treatment Strategies in Sars-Cov2 Infection, Acta Histochemica (2022)